Form 4: UnitedHealth Group Director Charles D. Baker Reports Acquisition of Deferred Stock Units
SEC Form 4 Filing
Director Charles D. Baker reports acquisition of 177 deferred stock units of UnitedHealth Group as part of quarterly compensation.
Summary
- Charles D. Baker, a director of UnitedHealth Group, reported the acquisition of 177 shares of common stock on July 1, 2024.
- These shares were acquired as deferred stock units, representing regular quarterly compensation for his service as a director.
- The price per share was $0.
- These deferred stock units are immediately vested but must be retained until completion of service on the Board.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and insider alignment with company performance.
Positives
- The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The acquisition of deferred stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of transaction: Acquisition of 177 shares of common stock as deferred stock units. |
| 07/02/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.